AU511704B2 - 1-aryloxy-2-hydroxy-3-aminopropanes - Google Patents

1-aryloxy-2-hydroxy-3-aminopropanes

Info

Publication number
AU511704B2
AU511704B2 AU25434/77A AU2543477A AU511704B2 AU 511704 B2 AU511704 B2 AU 511704B2 AU 25434/77 A AU25434/77 A AU 25434/77A AU 2543477 A AU2543477 A AU 2543477A AU 511704 B2 AU511704 B2 AU 511704B2
Authority
AU
Australia
Prior art keywords
aminopropanes
aryloxy
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU25434/77A
Other versions
AU2543477A (en
Inventor
W. Stacer U. and Lindner E Fritsch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU2543477A publication Critical patent/AU2543477A/en
Application granted granted Critical
Publication of AU511704B2 publication Critical patent/AU511704B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyridine Compounds (AREA)
AU25434/77A 1976-05-25 1977-05-24 1-aryloxy-2-hydroxy-3-aminopropanes Expired AU511704B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEDE2623,314 1976-05-25
DE2623314A DE2623314C2 (en) 1976-05-25 1976-05-25 1-aryloxy-2-hydroxy-3-aminopropanes, processes for their preparation and pharmaceuticals containing them

Publications (2)

Publication Number Publication Date
AU2543477A AU2543477A (en) 1978-11-30
AU511704B2 true AU511704B2 (en) 1980-09-04

Family

ID=5978907

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25434/77A Expired AU511704B2 (en) 1976-05-25 1977-05-24 1-aryloxy-2-hydroxy-3-aminopropanes

Country Status (18)

Country Link
JP (1) JPS5312827A (en)
AT (1) AT354421B (en)
AU (1) AU511704B2 (en)
BE (1) BE855041A (en)
CA (1) CA1108633A (en)
CH (5) CH637105A5 (en)
DE (1) DE2623314C2 (en)
DK (1) DK227177A (en)
ES (1) ES458957A1 (en)
FI (1) FI67698C (en)
FR (1) FR2353520A1 (en)
GB (1) GB1577670A (en)
HU (1) HU179198B (en)
IL (1) IL52148A (en)
IT (1) IT1077193B (en)
NL (1) NL7705587A (en)
SE (1) SE440903B (en)
ZA (1) ZA773120B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2415622A1 (en) * 1978-01-25 1979-08-24 Lipha AMINO ALCOHOLS DERIVED FROM METHYL ORTHO-HYDROXY CINNAMATE APPLICABLE ESPECIALLY AS MEDICINAL PRODUCTS
DE2824764A1 (en) * 1978-06-06 1979-12-20 Hoechst Ag NEW PYRIDYL PIPERAZINE DERIVATIVES AND PROCESS FOR THEIR PRODUCTION
ATE350T1 (en) * 1978-08-15 1981-11-15 Smithkline Corporation PROCESS FOR THE PREPARATION OF AROMATIC 2-HYDROXY-3-ISOPROPYL OR 2-HYDROXY-3-TERT-BUTYLAMINOPROPYL AETHERS.
FR2459235A1 (en) * 1979-06-14 1981-01-09 Sanofi Sa NOVEL SULFONYL-ANILINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
JPH0629833B2 (en) * 1984-06-15 1994-04-20 株式会社島津製作所 Fatigue testing machine
GB8603120D0 (en) * 1986-02-07 1986-03-12 Pfizer Ltd Anti-dysrhythmia agents
ES2244438T3 (en) 1999-05-24 2005-12-16 Mitsubishi Pharma Corporation PHENOXYPROPYLAMINE COMPOUNDS.
DE19941657A1 (en) * 1999-09-01 2001-03-08 Schwabe Willmar Gmbh & Co Cinnamic acid nitriles, process for their preparation and use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA945172A (en) * 1969-02-21 1974-04-09 Imperial Chemical Industries Limited Alkanolamine derivatives
FR2132570B1 (en) * 1971-04-09 1974-08-02 Lipha
BE791650R (en) * 1971-11-18 1973-05-21 Ici Ltd ALKANOLAMINE DERIVATIVES.
ES411826A1 (en) * 1973-02-20 1976-01-01 Liade Sa Lab Process for preparing pharmacologically active 1-aryloxy-2- propanolamines

Also Published As

Publication number Publication date
DE2623314A1 (en) 1977-12-08
AU2543477A (en) 1978-11-30
SE440903B (en) 1985-08-26
SE7706059L (en) 1977-11-26
AT354421B (en) 1979-01-10
DE2623314C2 (en) 1984-08-02
BE855041A (en) 1977-11-25
FI67698B (en) 1985-01-31
ZA773120B (en) 1978-04-26
CH637105A5 (en) 1983-07-15
ATA370177A (en) 1979-06-15
JPS6214545B2 (en) 1987-04-02
GB1577670A (en) 1980-10-29
DK227177A (en) 1977-11-26
HU179198B (en) 1982-09-28
IL52148A0 (en) 1977-07-31
CA1108633A (en) 1981-09-08
IL52148A (en) 1982-07-30
CH637107A5 (en) 1983-07-15
ES458957A1 (en) 1978-07-16
FI67698C (en) 1985-05-10
JPS5312827A (en) 1978-02-04
IT1077193B (en) 1985-05-04
FR2353520B1 (en) 1980-07-25
CH637108A5 (en) 1983-07-15
FI771630A (en) 1977-11-26
CH637109A5 (en) 1983-07-15
FR2353520A1 (en) 1977-12-30
CH640507A5 (en) 1984-01-13
NL7705587A (en) 1977-11-29

Similar Documents

Publication Publication Date Title
AU2107377A (en) Phathalanes
AU2329877A (en) Hentriakontapeptides
AU2350877A (en) Arylmalonamido-1-oxadethiacephalosporins
AU2289777A (en) E-2-propynyl-benzylamines
AU2268977A (en) 3-Phenyl-2-Oxazolidinones
AU2401277A (en) Trans-hexahydro-pyrido-indoles
AU2696477A (en) Pipejoint
AU2676477A (en) Surf-Ski
AU2838577A (en) Perhydro-aza-heterocycles
AU2372777A (en) Amidinoureas
AU2694177A (en) 7-b-oxyiminoacylcephalosporins
AU2464877A (en) Aminopiperidines
AU2921577A (en) Methanisation
AU2765177A (en) N-sulphenylated oxime-carbamates
AU2537677A (en) Aryltrifluoroethylamines
AU511704B2 (en) 1-aryloxy-2-hydroxy-3-aminopropanes
AU2370677A (en) Amidinopenicillanoyloxyalkyl amoxycillinates
AU2915477A (en) Corticods
AU2421077A (en) Benzoylethers
AU2228277A (en) 3-deoxyanthocyanidins
AU2912577A (en) 1-amino-2-hydroxy-3-heterocycloxy-propanes
AU2920677A (en) Imidazo-isoquinolines
AU2556877A (en) Substicuted 2-vinyl-chromones
AU2428577A (en) Bis-pencillanoyloxy-alkanes
AU2581877A (en) Neoviridogriseins